Cemiplimab Therapeutic Cheat Sheet
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con …
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con … 
You may want to make an extra effort to encourage your young adult patients to protect their skin from the sun. Recent surveys, as noted in The New York Times, showed that adults born after 1997 – those considered in Gen Z – were more likely to believe sun safety myths, including that daily sunscreen usage is more harmful than sun exposure.
Experts say that misinformation in this age group … 
Mohs Micrographic Surgery effectively removes skin cancer while preserving healthy tissue. But what happens when the procedure that’s supposed to help maintain aesthetics leads to long-lasting and highly distressing cosmetic outcomes?
That’s the focus of an observational study published in the May issue of the Journal of Drugs in Dermatology. Researchers looked at the factors that contribut … 
There’s never a wrong time to address photoprotection – including sunscreen use – with your patients, says Dr. Adam Friedman, co-chair of the ODAC Dermatology, Aesthetic & Surgical Conference. Next Steps in Derm, in partnership with ODAC, interviewed Dr. Friedman, who shared some of the challenges in getting patients to properly and consistently use sunscreen. Learn Dr. Friedman’s appr … 
Don’t forget about intralesional therapy as a treatment option for cutaneous malignancies, including non-melanoma and melanoma skin cancers, says Dr. Vishal A. Patel, director of cutaneous oncology at the GW Cancer Center. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Patel, who shared in which patients intralesional therapy may be … 